Mastering Current Management of CLL

How do you talk to patients with CLL about managing their disease with BTK inhibitors? Read my thoughts on how I use my interactions to educate patients about treatment options, planning for AEs, and improve outcomes.

Emily Bucholtz, RPh Released: April 29, 2021

Read expert answers to key questions asked by an audience of healthcare professionals during a live CCO webinar regarding the expert management of CLL/SLL including insights on clinical considerations when recommending BTK inhibitors.

Jeff Sharman, MD Released: May 21, 2021

Download these slides from a HOPA satelite live webinar to review the latest clinical data on the management of CLL using BTK inhibitors.

Jeff Sharman, MD Released: May 7, 2021

Download these slides from a HOPA satelite live webinar to review a pharmacist considerations for the management of CLL using BTK inhibitors, including patient and pharmacist resources.

Emily Bucholtz, RPh Released: May 7, 2021

Download this short summary slideset summarizing key points from a live CCO Webinar featuring expert hematologist and pharmacist perspectives on optimal care of patients with CLL in the clinic today.

Emily Bucholtz, RPh Jeff Sharman, MD Released: May 12, 2021

Watch this on-demand webcast from a live CCO webinar where pharmacist and physician experts review the current CLL/SLL treatment landscape and discuss important aspects of the pharmacist’s role in treatment and supportive care.

Emily Bucholtz, RPh Jeff Sharman, MD Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 24, 2021 Expired: No longer available for credit